Abstract
Comprehensive characterization of tumor-associated nonimmune stromal cells provides a robust resource for dissecting tumor microenvironment complexity and guiding stroma-targeted therapy development across multiple human cancer types.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have